Sage Journals: Discover world-class research

Open access

Research article

First published 2018

Budget impact analysis of rituximab biosimilar in Italy from the hospital and payer perspectives

Carla Rognoni, Arianna Bertolani, Claudio Jommi

Global & Regional Health Technology Assessment: Italian;Northern Europe and Spanish

Retricted access

Research article

First published 2021-4

Comparison of rituximab originator (MabThera ® ) to biosimilar (Truxima ® ) in patients with multiple sclerosis

Thomas Perez, Audrey Rico, Clémence Boutière [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2022

Rituximab biosimilar HLX01 versus reference rituximab in the treatment of diffuse large B-cell lymphoma: Real-world clinical experience

Weishang Deng, Sensen Yang, Changyuan Yang [...]

Journal of Oncology Pharmacy Practice

Free access

Research article

First published 2014-10

Comparative Nonclinical Assessments of the Proposed Biosimilar PF-05280586 and Rituximab (MabThera®)

Anne M. Ryan, Sharon A. Sokolowski, Chee-Keng Ng [...]

Toxicologic Pathology

Open access

Research article

First published 2019-3

The in-use stability of the rituximab biosimilar Rixathon®/Riximyo® upon preparation for intravenous infusion

William C Lamanna, Katharina Heller, Daniel Schneider [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2026

Navigating biosimilar transitions in IV rituximab therapy: Efficacy and safety insights from a real-world switching study

Abdülkadir Erçalışkan, Duygu Seyhan Erdoğan, Furkan Bahar [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2026

Physicochemical Stability of the Rituximab Biosimilar ABP 798 in Intravenous Bags Following Preparation and Storage

Jeremy Gastwirt, Jeff Brown, David Lai [...]

Hospital Pharmacy

Retricted access

Research article

First published 2021-8

Real-world intensive safety monitoring of biosimilars rituximab and trastuzumab in a Portuguese oncology hospital

Diogo Mendes, Joana Abrantes, Graça Rigueiro [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2022-10

National Control Laboratory Assessment of Quality of Rituximab Biosimilars in India

Nripendra Nath Mishra, Anu Sharma, Swati Shalini [...]

Monoclonal Antibodies in Immunodiagnosis & Immunotherapy

Open access

Research article

First published 2024

Switching from rituximab originator to GP2013 or CT-P10 biosimilars in autoimmune rheumatic diseases: drug retention rate and safety data from a multicentric retrospective cohort

Stefano Gentileschi, Cosimo Bruni, Carla Gaggiano [...]

Therapeutic Advances in Musculoskeletal Disease

Search results